RDW-to-Albumin Ratio as a Simple Biomarker for Early Mortality Risk After LVAD Implantation
Medicina · 30.04.2026 · 62 (5) · 853
DOI: 10.3390/medicina62050853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina, online erschienen am 30.04.2026. Verfasst von İbrahim Demir und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Istanbul Medipol University, Istanbul 34214, Turkey. Hauptthemen laut MEDLINE: Heart-Assist Devices, Erythrocyte Indices, Serum Albumin. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives: Early risk stratification remains challenging in patients undergoing left ventricular assist device (LVAD) implantation. Red cell distribution width (RDW) and serum albumin reflect systemic stress and nutritional reserve; their ratio (RDW-to-albumin ratio, RAR) may provide a simple preoperative index. We evaluated whether preoperative RAR is associated with early mortality after LVAD implantation. Materials and Methods: We conducted a retrospective cohort study of LVAD recipients (2019–2025). RAR was calculated as RDW (%) divided by albumin (g/dL) from preoperative blood tests obtained 24–48 h before surgery. The primary endpoint was in-hospital mortality. The secondary endpoint was 90-day survival. In-hospital mortality was analyzed using logistic regression with parsimonious adjustment for INTERMACS high-risk status (profiles 1–2 vs. 3–7); penalized regression was used to reduce small-sample bias. Discrimination was assessed using receiver operating characteristic (ROC) analysis. Ninety-day survival was evaluated using Cox proportional hazards models.
Results
Forty-seven patients were included (37 survivors; 10 in-hospital deaths). Higher RAR was associated with increased odds of in-hospital mortality and remained significant after adjustment for INTERMACS high-risk status (OR 1.68, 95% CI 1.04–2.90). INTERMACS high-risk status was strongly associated with in-hospital mortality (OR 17.89, 95% CI 3.19–138.07). RAR demonstrated good discrimination for in-hospital mortality (AUC 0.801, 95% CI 0.648–0.955). For 90-day survival, RAR showed a borderline association in unadjusted analysis (HR 1.28, 95% CI 0.98–1.68) and was not significant after adjustment (HR 1.20, 95% CI 0.89–1.63).
Conclusions
In this small single-center cohort, preoperative RAR was independently associated with in-hospital mortality after LVAD implantation. These findings should be considered hypothesis-generating and require external validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Istanbul Medipol University, Istanbul 34214, Turkey.
- Faculty of Medicine, Istanbul Medipol University, Istanbul 34214, Turkey.
- Department of Anesthesiology and Reanimation, Istanbul Medipol University, Istanbul 34214, Turkey.
- Department of Cardiology, Istanbul Medipol University, Istanbul 34214, Turkey.
ORCID-Profile: İbrahim Demir, Selinsu Güleşce
Zitieren
APA
Demir, İ., Ecemiş, B., Zorba, A., Güleşce, S., Yıldız, Y., Karaca, İ. O., & Erkanlı, K. (2026). RDW-to-Albumin Ratio as a Simple Biomarker for Early Mortality Risk After LVAD Implantation. Medicina, 62(5), 853. https://doi.org/10.3390/medicina62050853
Vancouver
Demir İ, Ecemiş B, Zorba A, Güleşce S, Yıldız Y, Karaca İO, et al. RDW-to-Albumin Ratio as a Simple Biomarker for Early Mortality Risk After LVAD Implantation. Medicina. 2026;62(5):853. doi:10.3390/medicina62050853
BibTeX
@article{Demir2026,
author = {Demir, İbrahim and Ecemiş, Bilge and Zorba, Ayşe and Güleşce, Selinsu and Yıldız, Yahya and Karaca, İbrahim Oğuz and Erkanlı, Korhan},
title = {RDW-to-Albumin Ratio as a Simple Biomarker for Early Mortality Risk After LVAD Implantation},
journal = {Medicina},
year = {2026},
volume = {62},
number = {5},
pages = {853},
doi = {10.3390/medicina62050853}
}
EUVIMED